Clinical Trials Directory

Trials / Completed

CompletedNCT04953390

Evaluating Benefits of Hearing Aid Microphone Directionality Technologies

Evaluating Benefits of Hearing Aid Microphone Directionality Technologies on Spatial Awareness and Speech Intelligibility

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Sonova AG · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the impact of hearing aid microphone directionality technologies and settings on speech understanding in noise for experienced hearing aid users. It will also evaluate the participant's spatial awareness of sounds using these different hearing aid microphone directionality technologies.

Conditions

Interventions

TypeNameDescription
DEVICEPhonak Audeo hearing aidCommercially available hearing aid with three different microphone settings: DIR1, DIR2, and DIR3
DEVICEPhonak hearing aid with multiple directionality settings, adjustable via a mobile appCommercially available hearing aid with multiple directionality settings which will be adjustable by user via a mobile app during a home trial period.

Timeline

Start date
2021-05-03
Primary completion
2021-07-02
Completion
2021-07-02
First posted
2021-07-08
Last updated
2022-11-09
Results posted
2022-11-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04953390. Inclusion in this directory is not an endorsement.

Evaluating Benefits of Hearing Aid Microphone Directionality Technologies (NCT04953390) · Clinical Trials Directory